Keith Tsoi
Overview
Explore the profile of Keith Tsoi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anvari S, Tsoi K
J Clin Med
. 2024 Jan;
13(2).
PMID: 38256527
Hepatitis B virus (HBV) reactivation in the setting of immunosuppressive therapy is an increasingly recognized and preventable cause of elevated liver enzymes and clinical hepatitis in treated patients. However, not...
2.
Coffin C, Haylock-Jacobs S, Doucette K, Ramji A, Ko H, Wong D, et al.
Viruses
. 2022 Dec;
14(12).
PMID: 36560672
Background: Hepatitis B surface antigen (HBsAg) loss is associated with improved clinical outcomes for individuals with chronic hepatitis B (CHB); however, the effects of varying HBsAg levels on clinical outcomes...
3.
Tam E, Tremblay J, Fraser C, Conway B, Ramji A, Borgia S, et al.
Can Liver J
. 2022 Aug;
3(3):251-262.
PMID: 35992533
Background: Canada was the first country to approve elbasvir/grazoprevir (EBR/GZR) for the treatment of chronic HCV infection for genotypes 1 and 4 with or without ribavirin and genotype 3 with...
4.
Osiowy C, Swidinsky K, Haylock-Jacobs S, Sadler M, Fung S, Wong D, et al.
JHEP Rep
. 2022 Apr;
4(5):100461.
PMID: 35360523
Background & Aims: HDV affects 4.5-13% of chronic hepatitis B (CHB) patients globally, yet the prevalence of HDV infection in Canada is unknown. To investigate the prevalence, genotype, demographics, and...
5.
Farag M, Fung S, Tam E, Doucette K, Wong A, Ramji A, et al.
J Viral Hepat
. 2021 Mar;
28(6):942-950.
PMID: 33749086
Tenofovir alafenamide fumarate (TAF) has high plasma stability resulting in fewer renal adverse events compared to tenofovir disoproxil fumarate (TDF) in chronic hepatitis B (CHB) patients. We aimed to study...
6.
Coffin C, Ramji A, Cooper C, Miles D, Doucette K, Wong P, et al.
CMAJ Open
. 2019 Oct;
7(4):E610-E617.
PMID: 31641059
Background: Published Canadian epidemiologic data on hepatitis B virus (HBV) infection include single-centre studies or are focused on Indigenous populations. We performed a study to characterize the demographic and clinical...
7.
Khan K, Fergani H, Ganguli S, Jalali S, Spaziani R, Tsoi K, et al.
J Can Assoc Gastroenterol
. 2019 Jul;
2(2):86-90.
PMID: 31294370
Aims: Our goals were to compare the effect of adding fentanyl to midazolam in a double-blinded, randomized, placebo-controlled trial and determine if fentanyl enhances sedation, increases adverse events or effects...
8.
Narula N, Tsoi K, Marshall J
Can J Gastroenterol
. 2011 Aug;
25(7):373-6.
PMID: 21876859
Patients with cirrhosis who develop spontaneous bacterial peritonitis (SBP) have been reported to experience a high incidence of renal impairment and mortality. Renal dysfunction is possibly related to altered systemic...
9.
Yuan Y, Tsoi K, Hunt R
Am J Med
. 2006 Sep;
119(9):719-27.
PMID: 16945603
Background: Selective serotonin reuptake inhibitors (SSRIs) represent a relatively new class of antidepressants. Several studies have reported bleeding disorders associated with the use of SSRIs, which are considered the result...
10.
Van Arsdell G, Tsoi K
Cardiol Clin
. 2002 Oct;
20(3):421-9.
PMID: 12371010
Subaortic stenosis can be a complex disease of multiple anatomic etiologies. At the core is either an elongated and narrow outflow tract as compared to normal or a fully muscle-rimmed...